Material Event Form 8 K

On August 30, 2024, Tonix Pharmaceuticals Holding Corp. (the "Company") increased the maximum aggregate offering price of the shares issuable under its Sales Agreement (the "Sales Agreement") with A.G.P./Alliance Global Partners, dated as of July 30, 2024, from $50,000,000 to $150,000,000. A copy of the legal opinion as to the legality of the shares issuable under the Sales Agreement is filed as Exhibit 5.01 attached hereto.